About this trial
Systemic sclerosis (SSc) is a chronic autoimmune connective tissue disease characterized by progressive fibrosis of the skin and internal organs. Fatigue, non-restorative sleep, and poor sleep quality are frequently reported among patients with SSc, yet these symptoms remain under-recognized and under-investigated in clinical practice. Despite growing awareness of the burden of sleep-related symptoms, there is a significant lack of objective data regarding sleep disturbances in this population, particularly those assessed using polysomnography (PSG).
Eligibility criteria
Qualifiers
None
Disqualifiers
Pre-existing primary sleep disorders diagnosed before SSc diagnosis
Use of sedatives or hypnotics within the last month that significantly alter sleep architecture
Severe psychiatric or neurological conditions
Refusal to participate in the study
Trial design
Treatments tested in this trial
- Polysomnography (PSG)